Wright and Harding are co-founders of M3 Biotechnology, Inc
Insulin resistance occurs when cells stop responding effectively to insulin signals, forcing the pancreas to produce more insulin to maintain blood sugar control
Individuals with diabetes characterized by HbA1c 6.5%, or a history of surgical or device-based obesity treatment, were excluded
10.1016/S0006-291X(84)80190-4 148 GodoyL
Retatrutide (LY3437943) is a synthetic 39-amino acid triple-hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously, commonly referenced in scientific literature for metabolic research, obesity mechanism studies, hepatic steatosis models, and energy expenditure pathway investigations in laboratory and preclinical environments